Full Text Journal Articles by
Author Philippe E Spiess

Advertisement

Find full text journal articles






NCCN Guidelines® Insights: Bladder Cancer, Version 2.2022.

Thomas W Flaig, Philippe E Spiess, Michael Abern, Neeraj Agarwal, Rick Bangs, Stephen A Boorjian, Mark K Buyyounouski, Kevin Chan, Sam Chang, Terence Friedlander, Richard E Greenberg, Khurshid A Guru, Harry W Herr, Jean Hoffman-Censits, Amar Kishan, Shilajit Kundu, Subodh M Lele, Ronac Mamtani, Vitaly Margulis, Omar Y Mian, Jeff Michalski, Jeffrey S Montgomery, Lakshminarayanan Nandagopal, Lance C Pagliaro, Mamta Parikh, Anthony Patterson, Elizabeth R Plimack, Kamal S Pohar, Mark A Preston, Kyle Richards, Wade J Sexton, Arlene O Siefker-Radtke, Matthew Tollefson, Jonathan Tward, Jonathan L Wright, Mary A Dwyer, Carly J Cassara, Lisa A Gurski,

The NCCN Guidelines for Bladder Cancer provide recommendations for the diagnosis, evaluation, treatment, and follow-up of patients with bladder cancer and other urinary tract cancers (upper tract tumors, urothelial carcinoma of the prostate, primary carcinoma of the urethra). These NCCN Guidelines Insights summarize the panel discussion behind recent important updates ... Read more >>

J Natl Compr Canc Netw (Journal of the National Comprehensive Cancer Network : JNCCN)
[2022, 20(8):866-878]

Cited: 0 times

View full text PDF listing >>



Novel portable apparatus for outpatient high-dose-rate (HDR) brachytherapy in penile cancer.

Anupam Rishi, Amarjit S Saini, Philippe E Spiess, Alice Yu, Daniel C Fernandez, Peter A S Johnstone, Arash O Naghavi,

<h4>Background</h4>Penile squamous cell carcinoma (PSC) is traditionally treated with surgical resection with significant morbidity. Penile sparing approaches, such as brachytherapy, require expertise, prolonged inpatient stays, poor patient convenience, and heterogenous plans with variable long-term toxicity. In this study, we describe the protocol for novel portable apparatus created for PSC, allowing ... Read more >>

Brachytherapy (Brachytherapy)
[2022, :S1538-4721(22)00111-8]

Cited: 0 times

View full text PDF listing >>



Advertisement


Disclaimer

0.5002 s